1-2 of 2
Manuela Kaspar
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Dose-Escalation and Signal-Generating Study of the Immunocytokine L19-IL2 in Combination with Dacarbazine for the Therapy of Patients with Metastatic Melanoma

Thomas K. Eigentler, Benjamin Weide, Filippo de Braud, Gianluca Spitaleri, Antonella Romanini, Annette Pflugfelder, Reinerio González-Iglesias, Annaelisa Tasciotti, Leonardo Giovannoni, Kathrin Schwager, Valeria Lovato, Manuela Kaspar, Eveline Trachsel, Hans D. Menssen, Dario Neri, Claus Garbe
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (24): 7732–7742.
https://doi.org/10.1158/1078-0432.CCR-11-1203
Published: 18 December 2011
View article titled, A Dose-Escalation and Signal-Generating Study of the Immunocytokine L19-IL2 in Combination with Dacarbazine for the Therapy of Patients with Metastatic Melanoma
Open the PDF for A Dose-Escalation and Signal-Generating Study of the Immunocytokine L19-IL2 in Combination with Dacarbazine for the Therapy of Patients with Metastatic Melanoma in another window
Includes: Supplementary data
Journal Articles

Antibody-Mediated Delivery of Interleukin-2 to the Stroma of Breast Cancer Strongly Enhances the Potency of Chemotherapy

Jessica Mårlind, Manuela Kaspar, Eveline Trachsel, Roberto Sommavilla, Stuart Hindle, Camilla Bacci, Leonardo Giovannoni, Dario Neri
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (20): 6515–6524.
https://doi.org/10.1158/1078-0432.CCR-07-5041
Published: 16 October 2008
View article titled, Antibody-Mediated Delivery of Interleukin-2 to the Stroma of Breast Cancer Strongly Enhances the Potency of Chemotherapy
Open the PDF for Antibody-Mediated Delivery of Interleukin-2 to the Stroma of Breast Cancer Strongly Enhances the Potency of Chemotherapy in another window
Includes: Supplementary data